Regulatory News Service Feed

Headline
Date
Download
Diaceutics Announces Key Leadership Appointment
July 29, 2025 07:07
Holding(s) in Company
July 25, 2025 12:07
Issue of Share Options / PDMR Shareholdings
July 23, 2025 07:07
22% Revenue Growth H125 representing 3-yr CAGR 25%
July 22, 2025 07:07
Expansion of PMx Commercialization Partnership
July 17, 2025 07:07
PDMR Shareholding/SIP and Total Voting Rights
June 30, 2025 07:06
Results of AGM
June 18, 2025 12:06
PDMR Shareholding /Share Incentive Plan and TVR
June 06, 2025 09:06
Notice of AGM and Posting of Annual Report
May 21, 2025 17:05
Transaction by Persons Closely Associated to PDMRs
May 15, 2025 07:05
FY 2024 Results - Strong Revenue Growth
May 13, 2025 07:05
PDMR Shareholding/Share Incentive Plan and TVR
April 29, 2025 16:04
Notice of Results
April 29, 2025 07:04
Block Listing Return
April 07, 2025 10:04
PDMR Shareholding/Share Incentive Plan and TVR
April 03, 2025 13:04
PMx Promotional Partner Contract Enhancement
March 26, 2025 07:03
Holding(s) in Company
March 06, 2025 15:03
PDMR Shareholding/Share Incentive Plan and TVR
March 03, 2025 15:03
Purchase of Shares and PDMR Shareholding
January 31, 2025 09:01
PDMR Shareholding/Share Incentive Plan
January 30, 2025 11:01
FY 2024 Trading Update - Strong Revenue Growth
January 28, 2025 07:01
Diaceutics Opens US Headquarters
January 14, 2025 07:01
New Service Launched & First Contract Signed
January 08, 2025 07:01
PDMR Dealings & Total Voting Rights
January 03, 2025 15:01
Holding(s) in Company
December 19, 2024 08:12
Holding(s) in Company
December 17, 2024 10:12
Diaceutics Wins New $5.1m Contract
December 17, 2024 07:12
Holding(s) in Company
December 10, 2024 15:12
Awarded UK Research Institute Grant Funding of £1m
December 05, 2024 07:12
Total Voting Rights
December 03, 2024 14:12
Expansion of US Commercial Activities
November 28, 2024 07:11
Capital Markets Webinar
November 05, 2024 07:11
Holding(s) in Company
November 04, 2024 07:11
PDMR Shareholding/Share Incentive Plan
October 30, 2024 14:10
Board Change Update
October 29, 2024 10:10
Issue of Share Options/PDMR Shareholdings
October 25, 2024 07:10
Cancellation of Share Premium Account
October 24, 2024 12:10
Diaceutics Announces Key Leadership Appointment
October 15, 2024 07:10
Holding(s) in Company
October 07, 2024 13:10
Block Listing Return
October 07, 2024 07:10
PDMR Shareholding/Share Incentive Plan
October 02, 2024 07:10
Board Changes
October 01, 2024 07:10
H1 2024 Results - Continued Performance & Growth
September 17, 2024 07:09
Notice of Results & Presentations
September 09, 2024 07:09
Appointment of Nominated Adviser and Broker
September 02, 2024 07:09
PDMR Shareholding/Share Incentive Plan
August 30, 2024 15:08
Diaceutics Launches Enhanced Rare-Disease Offering
August 27, 2024 07:08
Enterprise Partnership and Launch of PMx
August 19, 2024 07:08
Presenting at Canaccord Genuity Growth Conference
August 05, 2024 07:08
PDMR Shareholding/SIP and TVR
July 29, 2024 18:07
Issue of Share Options/PDMR Shareholdings
July 29, 2024 07:07
Board Changes
July 23, 2024 07:07
Revenue growth of 24% in H1 with 55% now recurring
July 23, 2024 07:07
Senior Management Appointments
July 11, 2024 07:07
PDMR Shareholding/SIP and Total Voting Rights
July 01, 2024 07:07
Result of AGM
June 24, 2024 13:06
"Precision Medicine in Oncology " Virtual Event
June 13, 2024 07:06
Diaceutics - Capital Markets Event
June 06, 2024 07:06
Notice of AGM and Posting of Annual Report
May 29, 2024 08:05
Data to be Presented at 2024 ASCO Annual Meeting
May 28, 2024 07:05
PDMR Shareholding/SIP and Total Voting Rights
May 24, 2024 15:05
Director / PDMR Shareholding
May 23, 2024 07:05
Revenue growth of 22% & order book growth of 57%
May 21, 2024 07:05
Two New Enterprise-Wide Engagements
May 16, 2024 07:05
Diaceutics - Capital Markets Event
May 14, 2024 07:05
Notice of Results & Presentations
May 01, 2024 07:05
PDMR Shareholding/SIP and TVR
April 30, 2024 07:04
Appointment of Amie Mc Neice as VP of Marketing
April 09, 2024 07:04
Block Listing Return
April 05, 2024 13:04
PDMR Shareholding/Share Incentive Plan
April 03, 2024 07:04
Director/PDMR/PCA Shareholding & TR1
April 02, 2024 07:04
Significant upgrade to Diaceutics' DXRX platform
March 21, 2024 07:03
Diaceutics forms landmark industry Forum
March 19, 2024 07:03
Director/PDMR Shareholding
March 07, 2024 07:03
PDMR Shareholding / SIP and TVR
March 01, 2024 09:03
Expanded lab network and data capabilities
February 27, 2024 07:02
Diaceutics PLC - Strategic alliance with KPMG
February 14, 2024 13:02
Appointment of VP, Scientific & Medical Services
February 05, 2024 07:02
PDMR Shareholding/Share Incentive Plan and TVR
February 01, 2024 12:02
Diaceutics PLC – Trading Update
January 30, 2024 07:01
Exercise of Warrant & Total Voting Rights
January 25, 2024 13:01
Diaceutics PLC – Financial Calendar Update
January 19, 2024 07:01
PDMR Shareholding/Share Incentive Plan
December 29, 2023 13:12
PDMR Shareholding/Share Incentive Plan and TVR
November 30, 2023 12:11
Diaceutics to attend Stifel Conference in NYC
November 30, 2023 07:11
Notification of Major Holdings
November 21, 2023 11:11
PDMR Shareholding/SIP & Total Voting Rights
October 31, 2023 12:10
PDMR Shareholding/Share Incentive Plan and TVR
October 11, 2023 13:10
Block Listing Application to AIM
October 02, 2023 15:10
Holding(s) in Company
September 29, 2023 11:09
Diaceutics PLC - Planned CEO Transition
September 26, 2023 07:09
Diaceutics PLC – Half Year Results
September 26, 2023 07:09
Diaceutics PLC – Directorate Changes
September 21, 2023 14:09
Attending 10th Annual HealthTech Investment Forum
September 07, 2023 07:09
Notice of Interim Results and Presentations
September 05, 2023 07:09
PDMR Shareholding/Share Incentive Plan
August 30, 2023 14:08
Diaceutics launches daily alerts for DXRX platform
August 29, 2023 07:08
Canaccord Genuity 43rd Annual Growth Conference
August 04, 2023 07:08
PDMR Shareholding/Share Incentive Plan
July 31, 2023 15:07
Trading Update and Notice of Results
July 25, 2023 07:07
PDMR Shareholding/Share Incentive Plan
June 29, 2023 12:06
Purchase and Sale of Shares and PDMR Shareholdings
June 06, 2023 07:06
USD 10.1 million multi-year enterprise engagement
June 05, 2023 07:06
PDMR Shareholding/Share Incentive Plan
May 31, 2023 17:05
Issue of Share Options/PDMR Shareholdings
May 19, 2023 10:05
Results of Annual General Meeting
May 18, 2023 11:05
PDMR Shareholdings
May 11, 2023 18:05
PDMR shareholdings
May 04, 2023 10:05
PDMR Shareholding/Share Incentive Plan
April 28, 2023 18:04
PDMR Shareholding
April 26, 2023 17:04
Notice of AGM and Posting of Annual Report
April 25, 2023 17:04
Final Results
April 17, 2023 07:04
PDMR Shareholding / Share Incentive Plan
April 03, 2023 14:04
Notice of Results and Presentations
March 20, 2023 07:03
Restoration - Diaceutics PLC
March 13, 2023 10:03
Further update regarding Silicon Valley Bank
March 13, 2023 10:03
Suspension - Diaceutics PLC
March 13, 2023 07:03
Update regarding Silicon Valley Bank
March 13, 2023 07:03
PDMR Shareholding/Share Incentive Plan
March 01, 2023 13:03
PDMR Shareholding/Share Incentive Plan
January 30, 2023 17:01
USD 7m enterprise engagements for data services
January 26, 2023 07:01
Trading Statement and Strategy Update
January 26, 2023 07:01
PDMR Shareholding/Share Incentive Plan
January 03, 2023 07:01
Change of Auditor
November 29, 2022 07:11
PDMR Shareholding/Share Incentive Plan
November 29, 2022 07:11
Sub-optimal testing impacts on cancer patients
November 01, 2022 07:11
PDMR Shareholding/Share Incentive Plan
October 31, 2022 14:10
PDMR Shareholding/Share Incentive Plan
October 05, 2022 17:10
Purchase of Shares and PDMR Shareholding
October 05, 2022 07:10
Half-year Report
September 27, 2022 07:09
PDMR Shareholding/Share Incentive Plan
September 12, 2022 12:09
Notice of Results and Presentations
September 08, 2022 07:09
PDMR Shareholding/Share Incentive Plan
August 08, 2022 07:08
Trading Update and Notice of Results
July 26, 2022 07:07
PDMR Shareholding/Share Incentive Plan
July 22, 2022 17:07
Multi-year contract with top five global pharma
June 13, 2022 07:06
New AI and ML Capabilities Enhance DXRX Platform
June 07, 2022 07:06
PDMR Shareholding/Share Incentive Plan
May 31, 2022 12:05
Share Options and PDMR Shareholdings
May 27, 2022 16:05
Result of AGM
May 26, 2022 15:05
PDMR Shareholding/Share Incentive Plan
May 11, 2022 14:05
Exercise of Warrant & Total Voting Rights
May 09, 2022 16:05
Contract Win
May 05, 2022 07:05
PDMR Shareholding/Share Incentive Plan
April 29, 2022 17:04
Notice of AGM and Posting of Annual Report
April 28, 2022 14:04
Purchase and Sale of Shares and PDMR Shareholdings
April 07, 2022 07:04
PDMR Shareholding/Share Incentive Plan
April 06, 2022 13:04
Conversion of Convertible Loan Notes & TVR
April 05, 2022 15:04
Issue of Share Options / PDMR Shareholdings
April 01, 2022 07:04
PDMR Shareholding/Share Incentive Plan
March 31, 2022 17:03
Final Results
March 22, 2022 14:03
Notice of 2021 Full Year Results
March 22, 2022 07:03
Confirmation of Directorate Change
March 18, 2022 14:03
Holding(s) in Company
March 16, 2022 17:03
Approval by CMS for enhanced data access
March 16, 2022 07:03
PDMR Shareholding/Share Incentive Plan
March 02, 2022 17:03
Investor Presentation
February 21, 2022 07:02
PDMR Shareholding/Share Incentive Plan
February 14, 2022 18:02
Contract with leading life sciences company
February 14, 2022 07:02
Director/PDMR Shareholding
February 04, 2022 11:02
Directorate Change
January 11, 2022 07:01
Trading Update and Notice of Results
January 11, 2022 07:01
PDMR Shareholding/Share Incentive Plan
January 04, 2022 07:01
Contract Win
December 14, 2021 07:12
Test Signal Launch and Contract Wins
December 09, 2021 07:12
PDMR Shareholding/Share Incentive Plan
December 01, 2021 17:12
PDMR Shareholding/Share Incentive Plan
November 09, 2021 16:11
PDMR Shareholding/Share Incentive Plan
October 01, 2021 13:10
Holding(s) in Company
October 01, 2021 12:10
Purchase/Transfer of Shares and PDMR Shareholdings
September 28, 2021 07:09
Nominated as finalists for Health Tech Awards 2021
September 21, 2021 07:09
Half-year Report
September 14, 2021 07:09
DXRX Platform Contract Win
September 13, 2021 07:09
Two new experts join the Diaceutics Advisory Panel
September 08, 2021 07:09
PDMR Shareholding/Share Incentive Plan
September 01, 2021 07:09
Notice of Investor Presentation
August 31, 2021 07:08
PDMR Shareholding/Share Incentive Plan
July 30, 2021 16:07
Trading Update
July 08, 2021 07:07
Issue of Share Options and PDMR Shareholdings
July 01, 2021 07:07
PDMR Shareholding/Share Incentive Plan
June 29, 2021 16:06
New Contract Wins
June 24, 2021 07:06
Purchase of Shares and PDMR Shareholding
June 18, 2021 07:06
Capital Markets Day and KPI Update
June 16, 2021 07:06
PDMR Shareholding/Share Incentive Plan
June 07, 2021 18:06
Notice of Capital Markets Day
June 07, 2021 07:06
Presenting data on COVID impact on cancer at ASCO
June 04, 2021 07:06
Holding(s) in Company
May 21, 2021 13:05
Change of Adviser
May 21, 2021 07:05
Result of AGM
May 19, 2021 15:05
LGC SeraCare Partnership
May 13, 2021 07:05
Sale of Shares and PDMR Shareholding
May 12, 2021 17:05
Holding(s) in Company
May 05, 2021 18:05
Sale of Shares and Director/PDMR Shareholding
May 04, 2021 15:05
Share Incentive Plan
April 30, 2021 11:04
Notice of AGM and posting of Annual Report
April 21, 2021 07:04
New Vice President of Operations in Asia
April 12, 2021 07:04
Transfer of Shares and Director/PDMR Shareholding
April 08, 2021 09:04
Transfer of Shares and Director/PDMR Shareholding
April 07, 2021 07:04
Issue of Share Options/PDMR Shareholdings
April 06, 2021 11:04
COVID-19 Testing Data licensing agreement
April 01, 2021 07:04
New lease agreement and related party transaction
March 30, 2021 07:03
Final Results
March 15, 2021 07:03
Notice of Results
March 08, 2021 07:03
New Vice President of Finance appointment
March 04, 2021 12:03
Quarterly media update
January 21, 2021 07:01
Holding(s) in Company
January 11, 2021 09:01
Trading update
January 11, 2021 07:01
Directorate Change
December 22, 2020 07:12
Directorate Change
December 22, 2020 07:12
Holding(s) in Company
December 10, 2020 15:12
European international award win
November 17, 2020 07:11
Holding(s) in Company
November 10, 2020 16:11
Commercial launch of DXRX
October 28, 2020 07:10
Second Price Monitoring Extn
September 07, 2020 14:09
Price Monitoring Extension
September 07, 2020 14:09
Price Monitoring Extension
September 07, 2020 11:09
Half-year Report
September 07, 2020 07:09
Notice of Results
August 27, 2020 07:08
New contract win for DXRX platform
July 22, 2020 07:07
Holding(s) in Company
July 09, 2020 07:07
Trading update
July 08, 2020 07:07
Second Price Monitoring Extn
July 06, 2020 16:07
Price Monitoring Extension
July 06, 2020 16:07
Holding(s) in Company
July 03, 2020 10:07
Issue of Share Options
July 03, 2020 07:07
Result of General Meeting
June 29, 2020 14:06
Holding(s) in Company
June 19, 2020 07:06
Exercise of warrant
June 11, 2020 14:06
Placing of £20.5 million
June 11, 2020 07:06
Result of AGM
May 19, 2020 14:05
AGM Statement
May 19, 2020 07:05
Diagnostic network for precision medicine update
May 18, 2020 07:05
Cancer testing & diagnosis suffers sharp downturn
April 29, 2020 07:04
Posting of Annual Report and Notice of AGM
April 23, 2020 07:04
Issue of Share Options
April 06, 2020 07:04
Belfast investor presentation
March 19, 2020 07:03
Second Price Monitoring Extn
March 17, 2020 09:03
Price Monitoring Extension
March 17, 2020 09:03
Second Price Monitoring Extn
March 16, 2020 11:03
Price Monitoring Extension
March 16, 2020 11:03
Final Results
March 16, 2020 07:03
Private investor briefing
March 12, 2020 14:03
Notice of Results
February 27, 2020 07:02
Belfast investor presentation
February 17, 2020 07:02
Growth & Innovation Forum 2020
February 06, 2020 07:02
Holding(s) in Company
January 17, 2020 14:01
Second Price Monitoring Extn
January 13, 2020 09:01
Price Monitoring Extension
January 13, 2020 09:01
Year-End Trading Update
January 13, 2020 07:01
Presentation at AICon 2019
November 25, 2019 07:11
Presentation at Big Data Belfast
October 24, 2019 07:10
Pharma Precision Medicine Readiness Report
October 21, 2019 07:10
Workshop presentation at EORTC
October 10, 2019 07:10
Poster presentation at ESMO
September 30, 2019 08:09
Dublin investor presentation
September 23, 2019 07:09
Half-year Report
September 09, 2019 07:09
Notice of Results
August 08, 2019 07:08
Appointment of Head of Global Data
August 08, 2019 07:08
Trading update
July 08, 2019 07:07
Investment in data lake
June 17, 2019 07:06
Investor presentation
May 28, 2019 07:05
Holding(s) in Company
March 25, 2019 16:03
Holding(s) in Company
March 25, 2019 07:03
Second Price Monitoring Extn
March 21, 2019 14:03
Price Monitoring Extension
March 21, 2019 14:03
Admission to AIM & First Day of Dealings
March 21, 2019 07:03

Latest Investor News

Annual & Interim Reports

Annual Report and Financial Statements for the year ended 31 December 2024
Annual & Interim Reports

Diaceutics Corporate Overview Presentation, May 2025
Group
Media

FY2024 Results Investor Meets Company Presentation

News

Notice of Full Year 2024 Results - Upcoming Investor and Analyst Presentations
Show More